Cite
HARVARD Citation
Kaur, S. et al. (2018). CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide. Neuro-oncology. 20 (4), pp. 484-493. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kaur, S. et al. (2018). CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide. Neuro-oncology. 20 (4), pp. 484-493. [Online].